Amarin Corp Plc (AMRN)

[rafunrafun]

Scripts for week ending March 25, 2022

Drug Industry TRx: -1.1% w/w; +8.5% y/y

Vascepa
TRx 69,986; -4.1% (-2,990) w/w; -15.8% y/y
NRx 32,432; -3.6% (-1,205) w/w; -16.5% y/y
Ref 37,554; -4.5% (-1,784) w/w; -15.2% y/y

Lovaza (Generic & Brand)
TRx 61,708; -2.6% (-1,665) w/w; -0.6% y/y
NRx 32,589; -1.5% (-500) w/w; +4.0% y/y
Ref 29,119; -3.8% (-1,165) w/w; -5.2% y/y

Generic Vascepa
TRx 30,492; -0.5% (-161) w/w; As % of total V: 30.3%
NRx 16,684; -2.3% (-392) w/w; As % of total V: 34.0%
Ref 13,808; +1.7% (+231) w/w; As % of total V: 26.9%

Generic Vascepa by Manufacturer
Hikma - TRx 7,260; (-280) w/w; Generic share 23.8%; Total V share 7.2%
Reddy - TRx 13,867; (-244) w/w; Generic share 45.5%; Total V share 13.8%
Apotex - TRx 9,365; (+363) w/w; Generic share 30.7%; Total V share 9.3%

Vascepa + Generic Vascepa
TRx 100,478; -3.0% (-3,151) w/w; +8.3% y/y
NRx 49,117; -3.1% (-1,597) w/w; +10.6% y/y
Ref 51,362; -2.9% (-1,553) w/w; +6.2% y/y